Time

Event

8:00 am – Lobby Level

Registration Opens

9:45 am – 2nd Floor

Welcome Remarks

• Sara Jane Demy, Founder & CEO, Demy-Colton

10:00 am – 2nd Floor 

Big Think Fireside Chat

Biopharma: What the Future Looks Like

• James Flynn, Managing Partner, Deerfield

Interviewed by:

• Sara Jane Demy, Founder & CEO, Demy-Colton

11:00 am – Lobby Level

One-to-One Meetings 

11:00 am – 2nd Floor

Spotlight Panel 1A 

Beyond the Cure: The Brave New World of Revolutionary Cancer Therapeutics 

Moderator:

• Erkang Ai, Counsel, Global Regulatory, Hogan Lovells

Panel:

• Robert Hoffman, CFO, Cytodyn Inc.
• Richard Kornbluth, President & CSO, Multimeric Biotherapeutics, Inc.
• Daniel Teper, CEO, Naya Therapeutics

11:00 am – 12th Floor 

Spotlight Panel 1B 

Rewiring Minds: Breakthroughs in Brain & CNS Health  

Moderator:

• Walter Greenleaf, Neuroscientist & Product Developer, Stanford University

Panel:

• Connor Glass, CEO & Founder, Phantom Neuro
• Beth Hoffman, CEO, Origami Therapeutics, Inc.
• Adam Rogers, CEO, NervGen Pharma 
• Arun Swaminathan, CEO, Coya Therapeutics, Inc. 
• Brent Vaughan, CEO & Founder, Eratos Therapeutics

12:00 pm – 2nd Floor & Lobby Level

Lunch

1:10 pm – 2nd Floor

“Big Think" Plenary Session 

Regenerative Medicine: The Future of Healing

2:00 pm – Lobby Level

One-to-One Meetings 

2:00 pm – 2nd Floor 

Dialogue 1A

Rare Disease Therapies: Challenges in Development and Regulatory Pathways

Moderator:

• Chris Vlahos, VP, External Innovation, Acadia Pharmaceuticals

2:00 pm – 12th Floor

Spotlight Panel 2B 

Where Code Meets Cells: Forging the TechBio Future

3:10 pm – 2nd Floor 

Spotlight Panel 3A 

Immunity Unleashed: Next-Gen Therapies & Immune Engineering

Panel:

• Wenzhi Tian, CEO, ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

3:10 pm – 12th Floor

Spotlight Panel 3B

Healthspan Horizons: Advancing Longevity Therapeutics 

Panel:

• Hans Keirstead, Chairman, Immunis, Inc.

4:15 pm – 2nd Floor

End of Day “Big Think" Plenary Session

The Great Biopharma Reset: Will Today’s Challenging Environment Result in a more Resilient Sector?

Moderator:

• Dennis Purcell, Founder & Senior Advisor, Aisling Capital

Panel:

• Jo Natauri, Founder & Managing Partner, Invidia Capital Management
• Umer Raffat, Equity Research, Evercore ISI
• Philip Ross, Vice Chairman, Global Healthcare Investment Banking, Jefferies LLC
• Eric Schmidt, Biotechnology Analyst, Cantor Fitzgerald